Stories about breast cancer that can inspire and inform

Blog  |  Newsroom

Dr. and Patient in Office

Practice-changing Research Results Announced At ASCO

Researchers and clinicians recently convened at the American Society of Clinical Oncology (ASCO), the world’s largest cancer conference, where the highly anticipated results of the DESTINY-Breast04 trial were announced.   DESTINY-Breast04 is a phase 3 trial that sought to determine if using [fam-] trastuzumab deruxtecan, an anti-HER2-antibody drug conjugate (ADC), was more effective than the standard-of-care treatment […]